Release Details

Third Quarter 2002 Results and Company Update

SAN DIEGO, Oct. 28 /PRNewswire-FirstCall/ --
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report third quarter financial results on Wednesday, October 30, 2002. Neurocrine will also host a Conference Call and Webcast to discuss its financial results and provide a company update on Thursday, October 31, 2002 at 11:00AM Eastern Standard Time (EST) /8:00AM Pacific Standard Time (PST). Participants may access the live Conference Call by dialing 1-800-711-5301 (US) or 785-832-0201 (International).  The call can also be accessed via the Webcast through the Company's website at www.neurocrine.com or through a
link provided by PRNewswire at: http://www.firstcallevents.com/service/ajwz368136534gf12.html  .

Gary A. Lyons, President and CEO of Neurocrine Biosciences and
Paul W. Hawran, Executive Vice President and CFO will be presenting the financial results for third quarter 2002 and will provide a Company update. If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Jones or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders.  Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com  .

Make Your Opinion Count - Click Here

http://tbutton.prnewswire.com/prn/11690X75984971

SOURCE  Neurocrine Biosciences, Inc.

    -0-                             10/28/2002

/CONTACT:  Claudia Jones or Elizabeth Foster of Neurocrine Biosciences, Inc., +1-858-658-7600/

/Web site:  http://www.neurocrine.com  /

/Audio:  http://www.firstcallevents.com/service/ajwz368136534gf12.html  /

(NBIX)

CO:  Neurocrine Biosciences, Inc.
ST:  California
IN:  MTC BIO HEA
SU:  CCA MAV

MW-EC
-- LAM108 --
6653 10/28/2002 15:56 EST http://www.prnewswire.com